IMU 4.00% 4.8¢ imugene limited

Ann: Initial Director's Interest Notice, page-67

  1. 971 Posts.
    lightbulb Created with Sketch. 231
    @Steini

    "Fact is that Her-Vaxx works better than anticipated, therefore an inadequate deal was rejected"

    I know we have speculated that this failed deal was the case, especially following the full dance card and goose comments. But is it indeed fact? Do you know this to be the case? Have the company shared this with you via email or similar?

    I'm genuinely interested. I'd love some transparency on what happened.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.